VOYA Investment Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.51M Buy
267,061
+59,052
+28% +$554K ﹤0.01% 1207
2025
Q1
$1.48M Buy
208,009
+179,180
+622% +$1.27M ﹤0.01% 1422
2024
Q4
$336K Sell
28,829
-2,213
-7% -$25.8K ﹤0.01% 2145
2024
Q3
$638K Sell
31,042
-866
-3% -$17.8K ﹤0.01% 1870
2024
Q2
$714K Sell
31,908
-49,133
-61% -$1.1M ﹤0.01% 1811
2024
Q1
$2.23M Sell
81,041
-13,679
-14% -$376K ﹤0.01% 1314
2023
Q4
$2.89M Buy
94,720
+38,170
+67% +$1.16M ﹤0.01% 1221
2023
Q3
$1.79M Buy
56,550
+21,703
+62% +$686K ﹤0.01% 1370
2023
Q2
$1.42M Sell
34,847
-43,270
-55% -$1.76M ﹤0.01% 1490
2023
Q1
$2.91M Sell
78,117
-37,678
-33% -$1.4M ﹤0.01% 1201
2022
Q4
$4.04M Buy
115,795
+2,950
+3% +$103K ﹤0.01% 1050
2022
Q3
$6.31M Buy
112,845
+42,530
+60% +$2.38M 0.01% 863
2022
Q2
$3.64M Sell
70,315
-114,058
-62% -$5.9M 0.01% 858
2022
Q1
$13.4M Buy
184,373
+157,452
+585% +$11.4M 0.03% 504
2021
Q4
$3.18M Buy
26,921
+160
+0.6% +$18.9K 0.01% 976
2021
Q3
$3.59M Buy
26,761
+1,662
+7% +$223K 0.01% 950
2021
Q2
$4.06M Buy
25,099
+1,050
+4% +$170K 0.01% 939
2021
Q1
$1.93M Buy
24,049
+1,998
+9% +$160K ﹤0.01% 1202
2020
Q4
$1.2M Buy
22,051
+5,482
+33% +$298K ﹤0.01% 1404
2020
Q3
$329K Buy
16,569
+1,299
+9% +$25.8K ﹤0.01% 1894
2020
Q2
$321K Sell
15,270
-4,196
-22% -$88.2K ﹤0.01% 1924
2020
Q1
$238K Buy
19,466
+899
+5% +$11K ﹤0.01% 2030
2019
Q4
$272K Buy
18,567
+3,874
+26% +$56.8K ﹤0.01% 2225
2019
Q3
$196K Hold
14,693
﹤0.01% 2251
2019
Q2
$241K Buy
14,693
+366
+3% +$6K ﹤0.01% 2199
2019
Q1
$245K Hold
14,327
﹤0.01% 2159
2018
Q4
$196K Buy
14,327
+1,518
+12% +$20.8K ﹤0.01% 2227
2018
Q3
$367K Hold
12,809
﹤0.01% 2033
2018
Q2
$350K Buy
+12,809
New +$350K ﹤0.01% 2053